Introduction
In England, the incidence of end-stage renal disease (ESRD), requiring dialysis or transplantation, has steadily increased from 67 per million population in 1991/92 to 92 per million population in 1998. 2 The UK renal registry and European registry 3, 4 data show that older patients and patients with co-morbid illnesses, especially diabetes, are being accepted in greater numbers for renal replacement therapy. Several retrospective studies [5] [6] [7] [8] have found an increased incidence of end-stage renal disease in people who ethnically originate from the Indian subcontinent (Indo-Asians) living in the UK, an ethnic minority whose size and median age is growing. There was a high demand for renal replacement therapy in this population, which was multiplied in older age groups. 7 There is also evidence to suggest that Indo-Asian people with diabetes, which is now the commonest single cause of ESRD in the UK, 2 are more susceptible to diabetic nephropathy than their White counterparts. 9 Given this, it is possible that the demand for renal replacement therapy may be rising exponentially in proportion to the growth of this population. It is important to study this in areas with a high proportion of Indo-Asian people, both to provide adequate health resources to meet this need and to suggest strategies to reduce the burden of ESRD. One of the reasons suggested for this increase in ESRD is reduced access to preventative health care that might reduce the progression of renal diseases. This has been noted in other ethnic minority groups outside the UK, 10 but there is little research on this in the Indo-Asian population in the UK. In addition, equity of therapy is a fundamental principle of the NHS and, as stated by the Renal Association: 'in making the appropriate choice of [dialysis] therapy, patient preference must be considered after informed guidance on options . . . '. 11 This principle may be more difficult to achieve in patients from ethnic minorities, because of language and cultural barriers, and if this is the case, attention should be paid to addressing this problem.
We present the results of a prospective, inception cohort of patients with ESRD who started renal replacement therapy in the North West, a part of the country with a large Indo-Asian population. We report the incidence of ESRD, and the characteristics and the length of specialist follow-up prior to inception of dialysis of this cohort of Indo-Asian patients. We also report on the treatment they received as they started renal replacement therapy in comparison to their White counterparts, and the choice they felt they had been offered.
Methods
Consecutive adult patients who started renal replacement therapy between 1 April 2000 and 31 December 2001 in Manchester, North Cheshire, South Cumbria and Lancashire were entered onto the study after their first dialysis session or the date of their transplant. All renal units in the region were visited regularly to ensure all patients were entered. They all had new ESRD as defined by the Renal Association Standards and Audit Subcommittee.
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Their demographic characteristics, renal diagnosis, mode of presentation to renal services, co-morbid conditions and initial mode of maintenance dialysis were recorded. Patients were interviewed as soon as logistically feasible regarding choice about dialysis modality and smoking history. Ethnicity, ascertained by patient questionnaires, was classified as White (of European and North American descent), Indo-Asian (of Indian subcontinent descent), Black (of African and West Indian descent) and Chinese (of South-East Asian descent), in keeping with the categories used by the UK Renal Registry. 2 The ERA/EDTA 12 system was used to classify primary renal diagnosis. In this classification, multisystem disease refers to diseases which affect other organs as well as the kidney, not including diabetes or vascular/hypertensive disease. The Carstairs Index, 1 a surrogate marker of social deprivation, was calculated from postcodes to give a deprivation quintile (the 1st quintile is the least socially deprived; the 5th the most). A Carstairs score, based on unemployment, no car, low social class and overcrowding, is given to each postcode sector, which are then divided into quintiles. The presence of diabetes, ischaemic heart disease, peripheral vascular disease, cerebrovascular disease and initial mode of maintenance dialysis therapy, including dialysis access, were recorded. The serum creatinine level at first renal referral was noted. Advanced chronic renal disease was defined as a serum creatinine >500 mmol/l (at this level progression to ESRD is almost inevitable). 13 Late referral, a marker for presenting as a uraemic emergency, was defined as a referral time less than 4 weeks before initiation of dialysis. 14 Annual acceptance rates for renal replacement therapy were calculated for the population living in Greater Manchester, because the population demographics and ethnic minority mix is clearly defined in this region by the government Office of National Statistics.
15,16 Binary logistic regression, using 'IndoAsian' as the outcome of interest, was used to give adjusted odds ratios.
Results 578 patients were entered onto the study between 1 April 2000 and 31 December 2001, and ethnicity was recorded in all of them: 9.5 % were Indo-Asian, 88 % were White and 2.5 % were from other ethnic minorities.
The overall acceptance rate for renal replacement therapy in Greater Manchester was 105 per million population per year. For the Indo-Asian population it was 342 per million per year compared with 91 per million per year for the White population (p < 0.001, Poisson regression). Age-standardized acceptance rates are shown in Table 1 . This shows the much higher incidence of ESRD in all age groups in Indo-Asian patients.
The characteristics of the two different groups are shown in Table 2 . Among patients starting renal replacement therapy, Indo-Asian patients were younger and more socially deprived. The proportion of the primary renal aetiologies responsible for ESRD is the same for Indo-Asian and White patients, with diabetic nephropathy the single commonest cause in both groups. More Indo-Asian patients presented with advanced chronic renal disease and as uraemic emergencies. There was no difference between the groups in terms of co-morbid illnesses at the inception of dialysis, nor in the mode of their initial maintenance dialysis and the choice they were given regarding this.
Multivariate analysis (shown in Table 3 ) confirmed that, by being of Indo-Asian descent, a patient with ESRD is more likely to be younger, more socially deprived and present late to specialist renal services. In addition, accounting for these differences means that Indo-Asian patients are 
Discussion
There have been no previous studies defining the annual acceptance rate for renal replacement therapy in Greater Manchester in different ethnic minorities, but results from a retrospective study in the Thames region in 1991/1992, 8 found an acceptance rate of 61 per million per year in the White population and 178 per million per year in the Indo-Asian population. Although there has been a greater increase in acceptance rate for renal replacement therapy in the Indo-Asian population in comparison with the White population over the last decade (92% increase compared with 49%), the Indo-Asian population in Greater Manchester has increased by 16.6% approximately during this time with a corresponding increase of 1.66% in the White population. 16 The population growth and the higher incidence of ESRD seen in the Indo-Asian population suggests that the acceptance rate should be even higher in this population. Further studies would have to be undertaken to determine if Indo-Asian patients are not being accepted for renal replacement therapy, and whether this is because of non-referral to renal services or nonacceptance by renal specialists, or refusal by IndoAsian patients to have dialysis. These results can only be interpreted as crude estimates, as they are based on population projections from the 1991 census, the Thames region has a higher proportion of Indo-Asians (7% as quoted in at the Thames study 8 in comparison with 4.9% in Greater Manchester in the latest estimates 16 ) and there may be regional differences in renal replacement therapy acceptance policies. To accurately determine the increase in ESRD, the same data would have to be collected in Greater Manchester, prospectively, over the next 5 to 10 years. The acceptance rate would also be affected by cross-boundary migration of patients. This study also accepts patients from the neighbouring regions of Lancashire and Cheshire, and so reduces some of this bias, and it is unlikely that there sufficient migration across its other borders to significantly alter these results.
A study following all the population of the North West, prospectively studying the development of renal disease, would provide invaluable information about risk factors for renal disease, eventually leading to effective prevention strategies. However, this study would be prohibitively expensive, as it would require a huge number of participants to be followed-up for a great length of time. Therefore this type of study should initially be undertaken in smaller populations who have a high risk of developing renal disease. Our study would suggest that Indo-Asian people living in the UK are an appropriate group to target for such future studies. This has been done in other ethnic minority groups worldwide [17] [18] [19] who have a similarly high incidence of renal disease, leading to the discovery of novel risk factors for development of renal disease.
Indo-Asian patients are more likely to have vascular/hypertensive renal disease. There are several studies that suggest that blood pressure control, glycaemic control and treatment of other vascular risk factors can slow the progression of renal disease. 18 It is likely that social deprivation and late referral to renal services (factors which are likely to be interconnected 20 ) do not allow IndoAsian patients to benefit from these treatment strategies. This has been noted in other populations with a high incidence of renal disease. A study to determine the reasons for the four-fold increase in ESRD in African American men found that adjusting for age, socioeconomic status and cardiovascular risk factors (diabetes, previous myocardial infarction, serum cholesterol, blood pressure and cigarettes smoked) reduced the relative risk of ESRD from 3.2 to 1.87 compared with White men. The Carstairs Index has not been validated in the Indo-Asian population. It is based on household characteristics of the population living in the postcode sectors, so should be accurate for postcode sectors which are predominantly Indo-Asian, but may be inaccurate in areas where the majority of the population are White. This study shows that a greater proportion of IndoAsian patients come to the attention of renal services with advanced renal disease, when renal replacement therapy is almost inevitable. 13 This means the opportunity to halt or slow the progression from chronic renal impairment to ESRD, requiring lifelong renal replacement therapy, has been lost. Equally worrying is that a greater proportion of Indo-Asian patients present as uraemic emergencies, having in addition missed the benefits of treatment for renal anaemia, renal osteodystrophy, nutritional advice and planning of their dialysis. It is not therefore surprising that presenting this late is associated with a higher mortality and morbidity. 21 These patients are put onto the renal transplant waiting list later in the course of their illness, and run the risk of being more difficult to successfully transplant, because of sensitization reactions to emergency blood transfusions. The Renal Association recommends referring everyone with a serum creatinine > 150 mmol/l to a nephrologist, 11 and it is apparent that this is less likely to be done if a patient is Indo-Asian. Further work needs to be done to establish whether Indo-Asian patients present to primary health care services later, or are not investigated for renal disease, or whether there is more difficulty with referral to specialist renal services in comparison to White patients.
The most effective method to reduce the burden of renal disease on individuals and the NHS is to prevent the occurrence of the disease. This study would suggest that research into screening IndoAsian patients (especially those at high risk, which would include older patients, diabetic patients, hypertensive patients and relatives of patients with renal disease 22 ) should be a priority, as a significant amount of their renal disease, in particular vascular renal disease, may be preventable. There is a specific programme in the US to screen patients susceptible to renal disease as part of a research project, 23 but this has not been adopted in the UK as yet. Screening and preventing diabetic renal disease has been highlighted in the National Service Framework for Diabetes, 24 and preventing vascular disease has been highlighted in the National Service Framework for Coronary Disease. 25 Both of these could be used to implement changes to reduce the incidence of renal disease. Screening for renal disease is not mentioned in the National Service Framework for Older People. 26 Further projects to highlight the need for early detection of renal disease in Indo-Asian patients by General Practitioners should be undertaken. There is a the National Service Framework for Renal Disease due for publication soon, and hopefully this will provide a means to implementing the changes needed to reduce the incidence of end-stage renal disease in the Indo-Asian population, as highlighted in this paper.
